It looks like 2016 is going to be a relatively lackluster year in terms of new drug approvals. Only 18 new molecular entity drugs have been approved year-to-date compared to 32 approved during the same time frame last year.
from RTT - Biotech http://ift.tt/2eVXFC3
via IFTTT
No comments:
Post a Comment